Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications

Claudiu T. Supuran, Jean-Yves Winum

John Wiley & Sons, Oct 22, 2009 - Medical - 912 pages

Brings together functional and structural informationrelevant to the design of drugs targeting zinc enzymes

The second most abundant transition element in living organisms, zinc spans all areas of metabolism, with zinc-containing proteins offering both established and potential drug targets. Drug Design of Zinc-Enzyme Inhibitors brings together functional and structural information relevant to these zinc-containing targets. With up-to-date overviews of the latest developments field, this unique and comprehensive text enables readers to understand zinc enzymes and evaluate them in a drug design context.

With contributions from the leaders of today's research, Drug Design of Zinc-Enzyme Inhibitors covers such key topics as:

• Major drug targets like carbonic anhydrases, matrix metalloproteinases, bacterial proteases, angiotensin-converting enzyme, histone deacetylase, and APOBEC3G

• Roles of recently discovered zinc-containing isozymes in cancer, obesity, epilepsy, pain management, malaria, and other conditions

• Cross reactivity of zinc-enzyme inhibitors and activators

• The extensive use of X-ray crystallography and QSAR studies for understanding zinc-containing proteins

• Clinical applications

An essential resource for the discovery and development of new drug molecules, Drug Design of Zinc-Enzyme Inhibitors gives researchers, professionals, students, and academics the foundation to understand and work with zinc enzyme inhibitors and activators.

What people are saying

User Review -

Saying the truth, this book could be better. Unfortunately, Google gave me a limited time to look through it and I have to rely on my first impression. I think, the book is adequate to what we used to know about MMPs and their inhibitors 10-15 years ago. However, you have to find something else if collection of antique artifacts is not your primary goal in Science. There is some progress made lately and this book simply does not reflect it. I feel deceived and disappointed. Perhaps, I will find something better.  

Contents

• PART I INTRODUCTION: 1
• PART II DRUG DESIGN OF CARBONIC ANHYDRASE INHIBITORS AND ACTIVATORS: 13
• PART III DRUG DESIGN OF MATRIX METALLOPROTEINASE INHIBITORS: 487
• PART IV DRUG DESIGN OF BACTERIAL ZINC PROTEASE INHIBITORS: 673
• PART V DRUG DESIGN STUDIES OF OTHER ZINCCONTAINING ENZYMES: 749
• Index: 989

About the author

Claudiu T. Supuran is a professor in the Department of Chemistry at the University of Florence, Italy. His main research interests include medicinal chemistry, design of enzyme inhibitors and activators, X-ray crystallography of metallo-enzymes, and metal complexes with biologically active ligands (metal-based drugs). He has published more than 400 original research papers in these fields.

Jean-Yves Winum is an assistant professor in the Department of Chemistry at the University of Montpellier 2 (Institut des Biomolécules Max Mousseron UMR CNRS 5247), France. His research interests are focused on organic/medicinal chemistry of metallo-enzyme inhibitors and activators.

Bibliographic information

• Title: Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications; Volume 14 of Wiley Series in Drug Discovery and Development
• Editors: Claudiu T. Supuran, Jean-Yves Winum
• Contributor: Binghe Wang
• Publisher: John Wiley & Sons, 2009
• ISBN: 0470508159, 9780470508152
• Length: 912 pages
• Subjects: Medical / Pharmacology